Home/Filings/4/A/0001474064-12-000055
4/A//SEC Filing

Melrose Glenn R 4/A

Accession 0001474064-12-000055

CIK 0000890465other

Filed

Sep 27, 8:00 PM ET

Accepted

Sep 28, 4:28 PM ET

Size

5.6 KB

Accession

0001474064-12-000055

Insider Transaction Report

Form 4/AAmended
Period: 2012-09-28
Melrose Glenn R
SVP, Human Resources
Transactions
  • Award

    Common Stock

    2012-09-17$4.59/sh+24,485$112,38624,485 total
    Exercise: $4.59Exp: 2022-09-17Common Stock (24,485 underlying)
Footnotes (2)
  • [F1]Revised Black Scholes value based on close of company's stock on September 17, 2012.
  • [F2]Stock options granted under the 2005 Omnibus Incentive Plan. The options become exercisable based on the following vesting schedule: 25% on the first anniversary of the grant and 6.25% every three months thereafter.

Issuer

NPS PHARMACEUTICALS INC

CIK 0000890465

Entity typeother

Related Parties

1
  • filerCIK 0001332933

Filing Metadata

Form type
4/A
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 4:28 PM ET
Size
5.6 KB